3M Co (MMM) stock
Close on Oct 30, 2026Market cap $89.91BP/E 31.0Yield 1.67%
Earnings
3M's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of 3M's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Jan 19, 2027Expected | – | – | – | – | – |
| Q3 FY2026ended Sep 30, 2026 | Oct 20, 2026before the open | $6.60B | +1.5% | $2.63 | $2.50 | Release |
| Q2 FY2026ended Jun 30, 2026 | Jul 21, 2026before the open | $6.50B | +3.2% | $1.78 | $2.40 | Release |
| Q1 FY2026ended Mar 31, 2026 | Apr 21, 2026before the open | $6.00B | 0.0% | $1.23 | $2.14 | Release |
| Q4 FY2025ended Dec 31, 2025 | Jan 20, 2026before the open | $6.10B | +1.7% | $1.07 | $1.83 | Release |
| Q3 FY2025ended Sep 30, 2025 | Oct 21, 2025before the open | $6.50B | +3.2% | $1.55 | $2.19 | Release |
| Q2 FY2025ended Jun 30, 2025 | Jul 18, 2025before the open | $6.30B | 0.0% | $1.34 | $2.16 | Release |
| Q1 FY2025ended Mar 31, 2025 | Apr 22, 2025before the open | $6.00B | -25.0% | $2.04 | $1.88 | Release |
| Q4 FY2024ended Dec 31, 2024 | Jan 21, 2025before the open | $6.00B | -25.0% | $1.33 | $1.68 | Release |
| Q3 FY2024ended Sep 30, 2024 | Oct 22, 2024before the open | $6.30B | -24.1% | $2.48 | $1.98 | Release |
| Q2 FY2024ended Jun 30, 2024 | Jul 26, 2024before the open | $6.30B | -24.1% | $2.17 | $1.93 | Release |
| Q1 FY2024ended Mar 31, 2024 | Apr 30, 2024before the open | $8.00B | 0.0% | $1.67 | $2.39 | Release |
| Q4 FY2023ended Dec 31, 2023 | Jan 23, 2024before the open | $8.00B | -1.2% | $1.70 | $2.42 | Release |
| Q3 FY2023ended Sep 30, 2023 | Oct 24, 2023before the open | $8.30B | -3.5% | -$3.74 | $2.68 | Release |
| Q2 FY2023ended Jun 30, 2023 | Jul 25, 2023before the open | $8.30B | -4.6% | -$12.35 | $2.17 | Release |
| Q1 FY2023ended Mar 31, 2023 | Apr 25, 2023before the open | $8.00B | -9.1% | $1.76 | $1.97 | Release |
| Q4 FY2022ended Dec 31, 2022 | Jan 24, 2023before the open | $8.10B | -5.8% | $0.98 | $2.28 | Release |
| Q3 FY2022ended Sep 30, 2022 | Oct 25, 2022before the open | $8.60B | -3.4% | $6.77 | $2.69 | Release |
| Q2 FY2022ended Jun 30, 2022 | Jul 26, 2022before the open | $8.70B | – | $0.14 | $2.48 | Release |
| Q1 FY2022ended Mar 31, 2022 | Apr 26, 2022before the open | $8.80B | – | $2.26 | $2.65 | Release |
| Q4 FY2021ended Dec 31, 2021 | Jan 25, 2022before the open | $8.60B | – | $2.31 | $2.31 | Release |
| Q3 FY2021ended Sep 30, 2021 | Oct 26, 2021before the open | $8.90B | – | $2.45 | $2.45 | Release |
| Q2 FY2021ended Jun 30, 2021 | Jul 27, 2021before the open | – | – | – | – | Filing |
| Q1 FY2021ended Mar 31, 2021 | Apr 27, 2021before the open | – | – | – | – | Filing |
| Q4 FY2020ended Dec 31, 2020 | Jan 26, 2021before the open | – | – | – | – | Filing |
| Q3 FY2020ended Sep 30, 2020 | Oct 27, 2020before the open | – | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
3M's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| Adjusted total sales growthnon-GAAP | FY2026 | +4.5% | – | New | Oct 20, 2026 |
| Adjusted total sales growthnon-GAAP | FY2026 | +4.5% | +4% | Raised | Jul 21, 2026 |
| adjusted organic sales growthnon-GAAP | FY2026 | +3.5% | – | New | Oct 20, 2026 |
| adjusted organic sales growthnon-GAAP | FY2026 | +3% | – | New | Jan 20, 2026 |
| 2026 adjusted operating income margin expansionnon-GAAP | FY2026 | 24.6% | – | New | Oct 20, 2026 |
| Adjusted operating income margin expansionnon-GAAP | FY2026 | 70 – 80 | – | New | Jul 21, 2026 |
| Adjusted EPSnon-GAAP | FY2026 | $9.10 – $9.15 | – | New | Oct 20, 2026 |
| Adjusted EPSnon-GAAP | FY2026 | $8.80 – $8.95 | $8.50 – $8.70 | Raised | Jul 21, 2026 |
| adjusted free cash flownon-GAAP | FY2026 | $4.80B | – | New | Oct 20, 2026 |
| Adjusted free cash flownon-GAAP | FY2026 | $4.70B – $4.90B | $4.60B – $4.80B | Raised | Jul 21, 2026 |
| Purchase of property, plant and equipment (PPE)GAAP | FY2026 | $1.10B | – | New | Oct 20, 2026 |
| Purchase of property, plant and equipment (PPE)GAAP | FY2026 | $1.10B | – | New | Jul 21, 2026 |
| Purchase of property, plant and equipment (PPE) | FY2026 | $1.10B | – | New | Apr 21, 2026 |
| Purchase of property, plant and equipment (PPE)non-GAAP | FY2026 | $1.10B | – | New | Jan 20, 2026 |
| 2026 adjusted effective tax ratenon-GAAP | FY2026 | 20% | – | New | Oct 20, 2026 |
| 2026 adjusted effective tax ratenon-GAAP | FY2026 | 20% | 20% | Lowered | Jul 21, 2026 |
| adjusted free cash flow conversionnon-GAAP | FY2026 | 100% | – | Raised | Jul 21, 2026 |
| Adjusted net income attributable to 3Mnon-GAAP | FY2026 | $4.60B – $4.70B | – | Lowered | Jul 21, 2026 |
| Adjusted operating cash flownon-GAAP | FY2026 | $5.90B | – | New | Oct 20, 2026 |
| Adjusted operating cash flownon-GAAP | FY2026 | $5.80B – $6.00B | $5.60B – $5.80B | Raised | Jul 21, 2026 |
| adjusted organic sales growthnon-GAAP | FY2026 | +3.5% | – | New | Jul 21, 2026 |
| Net cash provided by (used in) operating activitiesGAAP | FY2026 | $5.90B | – | New | Oct 20, 2026 |
| Net cash provided by (used in) operating activitiesGAAP | FY2026 | $5.80B – $6.00B | $5.60B – $5.80B | Raised | Jul 21, 2026 |
| Net income attributable to 3MGAAP | FY2026 | $4.60B – $4.70B | – | Lowered | Jul 21, 2026 |
| Net income attributable to 3Mnon-GAAP | FY2026 | $4.60B – $4.70B | – | Lowered | Jan 20, 2026 |
Guidance vs results
The last range 3M gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| FY2025 | Adjusted EPS | $7.95 – $8.05 | $8.06Σ4Q | Above range |
| FY2025 | Revenue growth | +2.5% | -6.39%Σ4Q | Below range |
Guidance history
Every forecast 3M put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Oct 20, 2026 | Purchase of property, plant and equipment (PPE) | FY2026 | $1.10B | New |
| Oct 20, 2026 | adjusted organic sales growth | FY2026 | +3.5% | New |
| Oct 20, 2026 | Adjusted EPS | FY2026 | $9.10 – $9.15 | New |
| Oct 20, 2026 | adjusted free cash flow | FY2026 | $4.80B | New |
| Oct 20, 2026 | 2026 adjusted operating income margin expansion | FY2026 | 24.6% | New |
| Oct 20, 2026 | Net cash provided by (used in) operating activities | FY2026 | $5.90B | New |
| Oct 20, 2026 | 2026 adjusted effective tax rate | FY2026 | 20% | New |
| Oct 20, 2026 | Adjusted operating cash flow | FY2026 | $5.90B | New |
| Oct 20, 2026 | Adjusted total sales growth | FY2026 | +4.5% | New |
| Jul 21, 2026 | Purchase of property, plant and equipment (PPE) | FY2026 | $1.10B | New |
| Jul 21, 2026 | Adjusted EPS | FY2026 | $8.80 – $8.95 | Raised |
| Jul 21, 2026 | Adjusted free cash flow | FY2026 | $4.70B – $4.90B | Raised |
| Jul 21, 2026 | Adjusted operating income margin expansion | FY2026 | 70 – 80 | New |
| Jul 21, 2026 | Adjusted operating cash flow | FY2026 | $5.80B – $6.00B | Raised |
| Jul 21, 2026 | adjusted free cash flow conversion | FY2026 | 100% | Raised |
| Jul 21, 2026 | 2026 adjusted effective tax rate | FY2026 | 20% | Lowered |
| Jul 21, 2026 | adjusted organic sales growth | FY2026 | +3.5% | New |
| Jul 21, 2026 | Net cash provided by (used in) operating activities | FY2026 | $5.80B – $6.00B | Raised |
| Jul 21, 2026 | Net income attributable to 3M | FY2026 | $4.60B – $4.70B | Lowered |
| Jul 21, 2026 | Adjusted net income attributable to 3M | FY2026 | $4.60B – $4.70B | Lowered |
| Jul 21, 2026 | Adjusted total sales growth | FY2026 | +4.5% | Raised |
| Apr 21, 2026 | Purchase of property, plant and equipment (PPE) | FY2026 | $1.10B | New |
| Apr 21, 2026 | Adjusted EPS | FY2026 | $8.50 – $8.70 | Reaffirmed |
| Apr 21, 2026 | Adjusted free cash flow | FY2026 | $4.60B – $4.80B | Reaffirmed |
| Apr 21, 2026 | adjusted effective tax rate | FY2026 | 20% | Reaffirmed |
| Apr 21, 2026 | Net cash provided by (used in) operating activities | FY2026 | $5.60B – $5.80B | New |
| Apr 21, 2026 | Adjusted operating cash flow | FY2026 | $5.60B – $5.80B | Raised |
| Apr 21, 2026 | Adjusted total sales growth | FY2026 | +4% | Reaffirmed |
| Jan 20, 2026 | Purchase of property, plant and equipment (PPE) | FY2026 | $1.10B | New |
| Jan 20, 2026 | adjusted organic sales growth | FY2026 | +3% | New |
| Jan 20, 2026 | Adjusted EPS | FY2026 | $8.50 – $8.70 | New |
| Jan 20, 2026 | Adjusted free cash flow | FY2026 | $4.60B – $4.80B | New |
| Jan 20, 2026 | adjusted effective tax rate | FY2026 | 20% | New |
| Jan 20, 2026 | Adjusted operating cash flow | FY2026 | $5.60B – $5.80B | New |
| Jan 20, 2026 | Net income attributable to 3M | FY2026 | $4.60B – $4.70B | Lowered |
| Jan 20, 2026 | Adjusted total sales growth | FY2026 | +4% | New |
| Oct 21, 2025 | Purchase of property, plant and equipment (PPE) | FY2025 | $900.00M | New |
| Oct 21, 2025 | Adjusted purchases of PPE (non-GAAP measure) | FY2025 | $900.00M | Reaffirmed |
| Oct 21, 2025 | Adjusted EPS | FY2025 | $7.95 – $8.05 | Raised |
| Oct 21, 2025 | Adjusted free cash flow (non-GAAP measure) | FY2025 | $4.30B – $4.50B | Raised |
| Oct 21, 2025 | adjusted free cash flow conversion | FY2025 | 100% | New |
| Oct 21, 2025 | adjusted organic sales growth | FY2025 | +2% | New |
| Oct 21, 2025 | Net cash provided by (used in) operating activities | FY2025 | $5.20B – $5.40B | Raised |
| Oct 21, 2025 | Net income attributable to 3M | FY2025 | $4.30B – $4.40B | Lowered |
| Oct 21, 2025 | Adjusted operating cash flow | FY2025 | $5.20B – $5.40B | Raised |
| Oct 21, 2025 | Adjusted net income attributable to 3M (non-GAAP measure) | FY2025 | $4.30B – $4.40B | Lowered |
| Oct 21, 2025 | Adjusted total sales growth | FY2025 | +2.5% | Reaffirmed |
| Jul 18, 2025 | Adjusted purchases of PPE (non-GAAP measure) | FY2025 | $900.00M | New |
| Jul 18, 2025 | adjusted organic sales growth | FY2025 | +2% | New |
| Jul 18, 2025 | Adjusted EPS | FY2025 | $7.75 – $8.00 | New |
| Jul 18, 2025 | Adjusted free cash flow | FY2025 | $4.20B – $4.50B | New |
| Jul 18, 2025 | Net cash provided by (used in) operating activities | FY2025 | $5.10B – $5.50B | New |
| Jul 18, 2025 | Net income attributable to 3M | FY2025 | $4.20B – $4.30B | Lowered |
| Jul 18, 2025 | Adjusted operating cash flow | FY2025 | $5.10B – $5.50B | New |
| Jul 18, 2025 | Adjusted net income attributable to 3M (non-GAAP measure) | FY2025 | $4.20B – $4.30B | Lowered |
| Jul 18, 2025 | Adjusted total sales growth | FY2025 | +2.5% | New |
| Apr 22, 2025 | Adjusted EPS | FY2025 | $7.60 – $7.90 | Reaffirmed |
| Jan 21, 2025 | Adjusted purchases of PPE | FY2025 | $1.00B | New |
| Jan 21, 2025 | Adjusted EPS | FY2025 | $7.60 – $7.90 | New |
| Jan 21, 2025 | Adjusted free cash flow | FY2025 | $4.10B – $4.30B | New |
| Jan 21, 2025 | adjusted free cash flow conversion | FY2025 | 100% | New |
| Jan 21, 2025 | adjusted effective tax rate | FY2025 | 20% | Lowered |
| Jan 21, 2025 | Adjusted operating cash flow | FY2025 | $5.20B – $5.30B | New |
| Jan 21, 2025 | Adjusted total sales growth | FY2025 | +0.5% – +1.5% | New |
| Jan 21, 2025 | adjusted organic sales growth | FY2025 | +2% – +3% | Raised |
| Oct 22, 2024 | Adjusted EPS | FY2024 | $7.20 – $7.30 | Raised |
| Jul 26, 2024 | adjusted EPS from continuing operations | FY2024 | $7.00 – $7.30 | Raised |
| Jul 26, 2024 | adjusted effective tax rate | FY2024 | 19% – 20% | Reaffirmed |
| Jul 26, 2024 | Adjusted total sales growth | FY2024 | -0.25% – +1.75% | Reaffirmed |
| Apr 30, 2024 | Adjusted earnings per share | FY2024 | $6.80 – $7.30 | Lowered |
| Apr 30, 2024 | 2024 adjusted effective tax rate | FY2024 | 19% – 20% | New |
| Apr 30, 2024 | 2024 adjusted other expense (income), net | FY2024 | $75.00M – $100.00M | Lowered |
| Apr 30, 2024 | Adjusted total sales growth | FY2024 | -0.25% – +1.75% | Lowered |
| Jan 23, 2024 | Adjusted EPS | FY2024 | $9.35 – $9.75 | New |
| Jan 23, 2024 | adjusted free cash flow conversion | FY2024 | 95% – 105% | New |
| Jan 23, 2024 | Adjusted operating cash flow | FY2024 | $6.50B – $7.10B | New |
| Jan 23, 2024 | Adjusted total sales growth | FY2024 | +0.25% – +2.25% | New |
| Oct 24, 2023 | adjusted EPS | FY2023 | $8.95 – $9.15 | Raised |
| Oct 24, 2023 | Adjusted full-year total sales growth | FY2023 | -5% | Lowered |
| Jul 25, 2023 | adjusted EPS | FY2023 | $8.60 – $9.10 | Raised |
| Jul 25, 2023 | Adjusted total sales growth | FY2023 | -5% – -1% | Raised |
| Apr 25, 2023 | Purchase of property, plant and equipment (PPE) | FY2023 | $1.50B – $1.80B | New |
| Apr 25, 2023 | Adjusted purchases of PPE | FY2023 | $1.30B – $1.60B | New |
| Apr 25, 2023 | Adjusted earnings per share | FY2023 | $8.50 – $9.00 | Reaffirmed |
| Apr 25, 2023 | Adjusted free cash flow | FY2023 | $4.20B – $5.00B | New |
| Apr 25, 2023 | adjusted free cash flow conversion | FY2023 | 90% – 100% | Reaffirmed |
| Apr 25, 2023 | 2023 adjusted effective tax rate | FY2023 | 18% – 19% | Lowered |
| Apr 25, 2023 | Adjusted operating cash flow | FY2023 | $5.80B – $6.30B | Reaffirmed |
| Apr 25, 2023 | adjusted total sales growth | FY2023 | -6% – -2% | Reaffirmed |
| Jan 24, 2023 | Adjusted earnings per share | FY2023 | $8.50 – $9.00 | New |
| Jan 24, 2023 | pre-tax restructuring charge | Q1 FY2023 | $75.00M – $100.00M | New |
| Jan 24, 2023 | adjusted free cash flow conversion | FY2023 | 90% – 100% | New |
| Jan 24, 2023 | Adjusted operating cash flow | FY2023 | $5.80B – $6.30B | New |
| Jan 24, 2023 | adjusted total sales growth | FY2023 | -6% – -2% | New |
| Oct 25, 2022 | Purchase of property, plant and equipment | FY2022 | $1.75B – $1.85B | New |
| Oct 25, 2022 | Adjusted earnings per share | FY2022 | $10.10 – $10.35 | Lowered |
| Oct 25, 2022 | Adjusted free cash flow | FY2022 | $4.90B – $5.60B | New |
| Oct 25, 2022 | adjusted free cash flow conversion | FY2022 | 85% – 95% | Lowered |
| Oct 25, 2022 | Acquisition and divestiture sales growth | FY2022 | -0.5% | New |
| Oct 25, 2022 | Foreign currency translation impact on sales | FY2022 | -4.5% | Lowered |
| Oct 25, 2022 | Operating cash flow | FY2022 | $6.80B – $7.40B | Raised |
| Oct 25, 2022 | Net income attributable to 3M | FY2022 | $5.80B – $5.90B | Lowered |
| Oct 25, 2022 | Organic sales growth | FY2022 | +1.5% – +2% | Lowered |
| Jul 26, 2022 | Adjusted earnings per share | FY2022 | $10.30 – $10.80 | Lowered |
| Jul 26, 2022 | GAAP earnings per share | FY2022 | $7.32 – $7.82 | Lowered |
| Jul 26, 2022 | Foreign currency translation | FY2022 | -4% | New |
| Jul 26, 2022 | adjusted free cash flow conversion | FY2022 | 90% – 100% | New |
| Jul 26, 2022 | Operating cash flow | FY2022 | $6.60B – $7.20B | New |
| Jul 26, 2022 | Total sales growth | FY2022 | -2.5% – -0.5% | New |
| Jul 26, 2022 | Organic sales growth | FY2022 | +1.5% – +3.5% | New |
| Apr 26, 2022 | adjusted earnings | FY2022 | $10.75 – $11.25 | New |
| Apr 26, 2022 | GAAP earnings per share | FY2022 | $9.89 – $10.39 | New |
| Oct 26, 2021 | Purchases of property, plant and equipment | FY2021 | $1.50B – $1.60B | New |
| Oct 26, 2021 | Earnings per share | FY2021 | $9.70 – $9.90 | New |
| Oct 26, 2021 | Free cash flow | FY2021 | $5.10B – $5.80B | New |
| Oct 26, 2021 | Net cash provided by (used in) operating activities | FY2021 | $6.70B – $7.30B | New |
| Oct 26, 2021 | free cash flow conversion | FY2021 | 90% – 100% | New |
| Oct 26, 2021 | Net income attributable to 3M | FY2021 | $5.70B – $5.80B | Lowered |
| Oct 26, 2021 | Organic local-currency sales growth | FY2021 | +8% – +9% | New |
| Oct 26, 2021 | Total sales growth | FY2021 | +9% – +10% | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases 3M filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Results
- Results
- Results
- Update
- Update
- Update
- Results
- Update
- Results
- Results
- Update
- Update